Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tambe

Showing results (611-620 of 750) with videos related to

Pageof 75
Sort By:
Viruses|January 25, 2025
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income CountriesAlex Durand Nka, Yagai Bouba, Wilfried Rooker Tsapi Lontsi, et al.
American Journal of Medical Genetics. Part A|March 26, 2019
First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeuticsKatherine A Rauen, Abeer Alsaegh, Shay Ben-Shachar, et al.
Frontiers in Medicine|October 7, 2024
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-studyWilly Le Roi Togna Pabo, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
BMC Health Services Research|August 1, 2021
Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS)Anand Krishnan, Prashant Mathur, Vaitheeswaran Kulothungan, et al.
BMJ Open|June 30, 2021
Baseline risk factor prevalence among adolescents aged 15-17 years old: findings from National Non-communicable Disease Monitoring Survey (NNMS) of IndiaPrashant Mathur, Vaitheeswaran Kulothungan, Sravya Leburu, et al.
Diagnostic Microbiology and Infectious Disease|February 5, 2026
Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countriesJoseph Fokam, Naomi-Karell Etame, Ezechiel Ngoufack Jagni Semengue, et al.
Plos One|March 2, 2021
National noncommunicable disease monitoring survey (NNMS) in India: Estimating risk factor prevalence in adult populationPrashant Mathur, Vaitheeswaran Kulothungan, Sravya Leburu, et al.
Frontiers in Public Health|March 27, 2024
Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparednessAlex Durand Nka, Yagai Bouba, Joseph Fokam, et al.
Heliyon|May 2, 2024
Performance characteristics of INDICAID antigen rapid diagnostic test on SARS-CoV-2 samples during the omicron wave in CameroonJoseph Fokam, Désiré Takou, Ezechiel Ngoufack Jagni Semengue, et al.
PLOS Global Public Health|May 10, 2024
XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current SARS-CoV-2 Wavelets with flu-like symptoms in Cameroon: A snapshot from genomic surveillanceJoseph Fokam, Ezechiel Ngoufack Jagni Semengue, Davy-Hyacinthe Gouissi Anguechia, et al.
Pageof 75

Showing results (611-620 of 750) with videos related to

Sort By:
Pageof 75
Viruses|January 25, 2025
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income CountriesAlex Durand Nka, Yagai Bouba, Wilfried Rooker Tsapi Lontsi, et al.
American Journal of Medical Genetics. Part A|March 26, 2019
First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeuticsKatherine A Rauen, Abeer Alsaegh, Shay Ben-Shachar, et al.
Frontiers in Medicine|October 7, 2024
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-studyWilly Le Roi Togna Pabo, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
BMC Health Services Research|August 1, 2021
Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS)Anand Krishnan, Prashant Mathur, Vaitheeswaran Kulothungan, et al.
BMJ Open|June 30, 2021
Baseline risk factor prevalence among adolescents aged 15-17 years old: findings from National Non-communicable Disease Monitoring Survey (NNMS) of IndiaPrashant Mathur, Vaitheeswaran Kulothungan, Sravya Leburu, et al.
Diagnostic Microbiology and Infectious Disease|February 5, 2026
Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countriesJoseph Fokam, Naomi-Karell Etame, Ezechiel Ngoufack Jagni Semengue, et al.
Plos One|March 2, 2021
National noncommunicable disease monitoring survey (NNMS) in India: Estimating risk factor prevalence in adult populationPrashant Mathur, Vaitheeswaran Kulothungan, Sravya Leburu, et al.
Frontiers in Public Health|March 27, 2024
Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparednessAlex Durand Nka, Yagai Bouba, Joseph Fokam, et al.
Heliyon|May 2, 2024
Performance characteristics of INDICAID antigen rapid diagnostic test on SARS-CoV-2 samples during the omicron wave in CameroonJoseph Fokam, Désiré Takou, Ezechiel Ngoufack Jagni Semengue, et al.
PLOS Global Public Health|May 10, 2024
XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current SARS-CoV-2 Wavelets with flu-like symptoms in Cameroon: A snapshot from genomic surveillanceJoseph Fokam, Ezechiel Ngoufack Jagni Semengue, Davy-Hyacinthe Gouissi Anguechia, et al.
Pageof 75